US Stock MarketDetailed Quotes

TKPHF TAKEDA PHARMACEUTICAL CO LTD

Watchlist
  • 25.380
  • -1.220-4.59%
15min DelayClose Dec 18 16:00 ET
40.23BMarket Cap21.60P/E (TTM)

About TAKEDA PHARMACEUTICAL CO LTD Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTKPHF
Company NameTAKEDA PHARMACEUTICAL CO LTD
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketPink Market
Employees49281
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data